Who is pausing immunosuppressive medication for COVID-19 vaccination? Results of an exploratory observational trial

Who is pausing immunosuppressive medication for COVID-19 vaccination? Results of an exploratory observational trial

Abstract Background The influence of immunosuppressive therapy on immunogenicity after COVID-19 vaccination remains unclear. This study surveys patients who receive immunosuppressive therapy about whether or not they paused their immunosuppressive medication while receiving SARS-CoV-2 vaccination. M...

Full description

Bibliographic Details
Main Authors: Dominik Schröder, Stephanie Heinemann, Gloria Heesen, Frank Klawonn, Marie Mikuteit, Jacqueline Niewolik, Sandra Steffens, Georg Behrens, Alexandra Jablonka, Frank Müller
Format: Article
Language:English
Published: BMC 2022-06-01
Series:European Journal of Medical Research
Subjects:
Immunosuppression
SARS-CoV-2
COVID-19
Immunization
Immunogenicity
Drug compliance
Online Access:https://doi.org/10.1186/s40001-022-00727-7

Internet

https://doi.org/10.1186/s40001-022-00727-7

Similar Items